{"result": "(\"entity\"<|>CRIPTORQUIDIA<|>EVENT<|>Criptorquidia is a medical condition characterized by a testicle that has not descended into the scrotum by the age of 4 months, which can lead to various complications if untreated.)\n##\n(\"entity\"<|>HCG<|>ORGANIZATION<|>HCG, or human chorionic gonadotropin, is a hormone used in medical treatments to stimulate testicular descent in cases of cryptorchidism.)\n##\n(\"entity\"<|>HMG<|>ORGANIZATION<|>HMG, or human menopausal gonadotropin, is a hormone that acts on FSH and LH and is used in conjunction with HCG to improve sperm response in cryptorchidism treatment.)\n##\n(\"entity\"<|>ORQUIDOPEXIA<|>EVENT<|>Orquidopexia is the surgical procedure of placing a testicle in the scrotum, which is the preferred treatment for most cases of cryptorchidism.)\n##\n(\"entity\"<|>TESTÍCULO<|>PERSON<|>Testículo refers to the male reproductive gland that produces sperm and hormones, which can be affected by conditions like cryptorchidism.)\n##\n(\"entity\"<|>TESTÍCULOS CRIPTORQUÍDICOS<|>PERSON<|>Testículos criptorquídicos are undescended testicles that may require medical or surgical intervention to prevent complications.)\n##\n(\"relationship\"<|>CRIPTORQUIDIA<|>ORQUIDOPEXIA<|>Orquidopexia is the surgical treatment of choice for cryptorchidism, aimed at placing the undescended testicle in the scrotum<|>9)\n##\n(\"relationship\"<|>HCG<|>TESTÍCULO<|>HCG is used to stimulate the descent of the testicle in cases of cryptorchidism<|>7)\n##\n(\"relationship\"<|>HMG<|>TESTÍCULO<|>HMG is used in conjunction with HCG to improve the response of the testicle in cryptorchidism treatment<|>7)\n##\n(\"relationship\"<|>TESTÍCULO<|>TESTÍCULOS CRIPTORQUÍDICOS<|>Testículos criptorquídicos are a specific condition affecting the testicle that requires treatment<|>8)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: mantenerse en el nivel para mujeres premenopáusicas (100 a 200 pg/ml y 50 ng/dl, respectivamente).\n\nReferencias:\n- Hembree WC, Cohen-Kettenis PT, Gooren L, Hannema SE, Meyer WJ, Murad MH, et al. Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society* Clinical Practice Guideline. J Clin Endocrinol Metab [Internet]. 2017;102(11):3869-903. https://doi.org/10.1210/jc.2017-01658\n\n## 6.7 Otros\n\n22. Con respecto al tratamiento médico de la criptorquidia, señale la respuesta cierta:\n   A. El tratamiento hormonal está asociado a altas tasas de respuesta (>80%) comparado con placebo.\n   B. El tratamiento con análogos de GnRH tiene mayor tasa de respuestas que el tratamiento con hCG.\n   C. La localización inicial de los testes no influye en las tasas de respuesta.\n   D. Todas son falsas.\n\n### COMENTARIO\n\nSe entiende por criptorquidia un testículo oculto que no se encuentra dentro del escroto y no ha descendido espontáneamente a los 4 meses de edad. Los testículos criptorquídicos pueden estar ausentes (por agenesia o atrofia, uni o bilateral) o no descendidos (quedando a nivel abdominal, intracanalicular o bien supraescrotal).\n\nHay que diferenciar la criptorquidia de los testes retráctiles o \"en ascensor\" que se encuentran descendidos en región escrotal, pero que suben a la región supraescrotal por el reflejo cremastérico, volviendo a su lugar cuando este no actúa. Son frecuentes.\n\nEl objetivo del tratamiento de la criptorquidia es llevar el testículo criptorquídico al escroto si es viable, o extirparlo si no es viable, con el fin de evitar torsiones, lesiones, disminuir el riesgo de infertilidad o malignidad, y mejorar la adaptación psicológica del paciente.\n\nEl tratamiento médico pretende conseguir el descenso del testículo mediante un aumento de testosterona a nivel intratesticular con la hCG (gonadotrofina coriónica humana) y los aGnRH (análogos de GnRH). La asociación de hCG con HMG (gonadotrofina menopáusica humana con acción FSH y LH) o el tratamiento con GnRH se ha defendido con la intención de mejorar la respuesta espermática.\n\nNinguno de estos tratamientos médicos ha demostrado definitivamente su eficacia en cuanto a descenso testicular, no superando el 20%, con otro 20% de reascensos en quienes lo consiguen. La respuesta al tratamiento médico de las criptorquidias se relaciona con la localización; responden mejor los más distales, y se puede interpretar como respuesta el descenso de un testículo en ascensor más que una verdadera criptorquidia. El tratamiento médico se plantea para testículos criptorquídicos que se puedan bajar en la exploración hasta la parte alta del escroto, pero no puedan descender completamente, o que se encuentran en localización supraescrotal. Estos tratamientos son bien tolerados, aunque se han descrito signos de virilización reversibles (aumento del pene y/o del vello pubiano, o hiperpigmentación escrotal).\n\nTambién se ha planteado como adyuvante antes o después del tratamiento quirúrgico, para mejorar la fertilidad, por mejorar las características del semen, pero los resultados son también contradictorios.\n\nEl tratamiento quirúrgico es el tratamiento de elección para la mayoría de las criptorquidias. Debe recomendarse tan pronto como sea posible en testículos palpables, tras los 4 meses de edad y antes de los 2 años (preferentemente antes del año) para mejorar en lo posible su crecimiento y capacidad reproductora, que puede quedar comprometida en estos pacientes. El tratamiento antes de la pubertad reduce además el riesgo de cáncer y torsión testicular. Es un tratamiento eficaz en más del 90% de casos, y las complicaciones son poco frecuentes en manos expertas (atrofia, reascenso, hernia inguinal, infección o sangrado).\n\nLa orquidopexia es la técnica de elección y consiste en la colocación quirúrgica del testículo en el escroto por vía inguinal o escrotal, si está localizado el testículo y lo permite el tamaño y vascularización.\n\nReferencias:\n- Cooper CS, Docimo SG. Undescended testes (cryptorchidism) in children: Management. Drutz JE et al, eds. UpToDate. Waltham, MA: UpToDate Inc. https://www.uptodate.com (Apr 02 2019.)\n- Hadziselimovic F. Is Hormonal Treatment of Congenital Undescended Testes Justified? A Debate. Sex Dev. 2019;13(1):3-10. doi: 10.1159/000496418.\n---\n#\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}